Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania nuclear power producer Nuclearelectrica has announced that its subsidiary FPCU Feldioara signed a non-binding term sheet with Critical Metals Corp to explore establishing a joint venture for rare metals processing in Romania.
Romania's trade balance deficit (FOB/CIF) reached €27.493 billion in the first ten months of this year, increasing by €275.7 million (+1%) compared to the same period in 2024, according to data published by the National Institute of Statistics (INS).
More than half of households globally (57%) are worried about annual broadband price increases and think these increases are unfair and unreasonable (60%), according to the latest EY decoding the digital home study.
Romanian private healthcare network MedLife has reached a market capitalisation of €1 billion at the Bucharest Stock Exchange (BVB), around nine years after the company went public.
Romania's air passenger traffic increased by 8.2% in the first nine months of 2025 compared to the same period in 2024, rising from 19.8 million to 21.4 million passengers, according to data from the National Institute of Statistics.